Queens of Quality Podcast

In this episode of Queens of Quality, co-hosts Michelleanne and Jen engage with guests Emily Barker and Steve Thompson in a conversation on AI and ethics. Major topics include AI's difficulty in dealing with negative constructs, limitations, and the role of the Algorithm Review Board (ARB). The team frames the conversation by comparing AI to different aspects of human behavior, illustrating its limitations. They delve into negative programming and its implications on pattern matching in AI. The episode also highlights the importance of a diverse cross-section of people in ARB to minimize bias and raise various ethical considerations. Lastly, it expands on the ARB's potential in handling AI's limitations from different perspectives, confirming their readiness to tackle new challenges and inviting more diverse voices to join the conversation.00:31 Introduction and Welcome00:54 Discussion on AI and Ethics01:48 Understanding Negative Programming in AI02:12 Exploring AI's Limitations: Pattern Matching and Negation04:27 AI's Struggle with 'No' and 'Not'07:33 AI's Lack of Self-Awareness and Empathy09:06 The Role of AI as a Tool, Not a Replacement10:16 The Importance of Human Involvement in AI11:00 AI's Struggle with Uncertainty14:10 The Role of the Algorithm Review Board (ARB)22:32 Conclusion and Invitation for Participation Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Connect with Steve ThompsonLinkedIn: https://www.linkedin.com/in/stevethompsonsocal/Connect with Emily BarkerLinked In: https://www.linkedin.com/in/mannbark/Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: hello@metisconsultingservices.com

In this episode, the hosts, Michelleanne and Jenn, continued their conversation with Steve Thompson and special guest Emily Barker, an experienced tech professional focusing on biopharma, biotech, and AI. They discussed Emily's unique perspective, bringing tech and biopharma together, delving further into AI ethics, and creating an algorithm review board. They spoke on using AI ethically and avoiding potential catastrophes. The podcast touched on the constant evolution of AI, the careful and informed approach to its use in the life sciences field, and the importance of bringing together diverse perspectives to shape its future in a beneficial manner. They highlighted the significance of creating an AI lexicon to ensure all industry players speak the same language and invited community participation.00:31 Introduction and Guest Introduction01:25 Discussing AI Ethics and Algorithm Review Board02:51 Understanding the Complexity of AI Landscape03:56 The Importance of Language Consistency in AI04:47 Exploring the Concept of Algorithm Review Board06:10 The Challenges of Reproducing AI Results07:44 Understanding the Algorithm in AI10:47 The Role of Algorithm Review Board in AI12:21 The Importance of Involving Diverse Perspectives in AI13:01 The Future of AI in Life Sciences23:02 The Need for Pre-Work in AI26:48 Conclusion and Call to Action Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Connect with Steve ThompsonLinkedIn: https://www.linkedin.com/in/stevethompsonsocal/Connect with Emily BarkerLinked In: https://www.linkedin.com/in/mannbark/Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: hello@metisconsultingservices.com

In this episode of "Queens of Quality," hosts Michelleanne, Jen, and guest Steve Thompson delve deeper into the ethical implications of AI in life sciences. They emphasize the necessity of an Algorithm Review Board (ARB) to oversee the ethical use of AI in clinical trials and beyond. Acknowledging the rapid evolution of technology and its complex application in healthcare, they stress the importance of collaboration and diverse representation to ensure ethical practices.Tune in!During this episode, you will learn about;00:31 Introduction and Welcome Back00:40 Discussion on AI and Clinical Trials01:17 The Concept of Algorithm Review Board01:44 The Evolution and Impact of Technology02:35 The Synthetic Patient Concept04:10 The Need for Ethical Standards in AI05:42 The Role of Institutional Review Boards08:49 The Importance of Diverse Representation10:48 The Idea of Algorithm Review Board10:59 The Need for Collaboration and Inclusion12:15 The Risks of Misusing AI in Medicine20:26 The Importance of Preventative Measures21:12 Call to Action for Audience Participation24:30 Conclusion and Invitation for Future Discussions Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Connect with Steve ThompsonLinkedIn: https://www.linkedin.com/in/stevethompsonsocal/Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: hello@metisconsultingservices.com

In this engaging episode of "Queens of Quality," Michelleanne welcomes Steve Thompson to delve into the realm of ethical AI in life sciences. They explore the excitement and challenges surrounding AI's evolution, emphasizing the critical need for an ethical compass in its application. With insightful discussions on bias, data integrity, and the multidisciplinary approach necessary for success, Steve and Michelleanne highlight the intricate balance between technological advancement and ethical responsibility. Their conversation teases a promising solution, promising a deeper exploration in the next episode.Tune in!During this episode, you will learn about;0:00:32 - Introduction and Guest Introduction (Steve Thompson) - Discussing the Importance of Ethical AI0:01:47 - Guest's Background and Journey into AI0:02:11 - The Current State and Future of AI0:03:22 - The Ethical Dilemmas in AI0:05:34 - The Importance of Continuous Improvement in AI0:11:35 - The Challenges of Creating Synthetic Patients0:13:32 - The Role of AI in Risk Management0:18:48 - The Importance of Multidisciplinary Teams in AI0:24:30 - The Ethical Considerations in AI0:28:48 - Conclusion and Teaser for Next Episode      Love the show? Subscribe, Rate, Review, Like, and Share! Let’s Connect! Connect with Steve ThompsonLinkedIn: https://www.linkedin.com/in/stevethompsonsocal/Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: hello@metisconsultingservices.com

Join Michelleanne and Jenn in the Season 2 finale of Queens of Quality as they reflect on the evolution of quality and compliance in the pharmaceutical industry. Dive into insightful discussions on soft skills, inspection readiness, regulatory changes, and the importance of simplicity in this dynamic field. Get ready for engaging conversations and a sneak peek into what's ahead in the next season! Tune in! During this episode, you will learn about;0:00:32 - Introduction and Season Wrap-up0:01:07 - Discussion on Soft Skills in Quality0:02:45 - Insights on Inspection Readiness0:04:03 - Changes in Regulations and Future Trends0:06:44 - The Importance of Being a Quality Human Being0:08:25 - The Need for Quality in Every Role0:10:44 - Conclusion and Look Forward to Next Season Love the show? Subscribe, Rate, Review, Like, and Share! Let’s Connect! Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com 

Welcome to another episode of Queens of Quality. In this episode, we explore the key concepts of ICH (International Council on Harmonization), with a focus on the recent revisions to ICH E6R3 and ICH E8R1. These revisions bring significant changes to the pharmaceutical industry's regulatory landscape, emphasizing the importance of quality by design in clinical trials.Tune in!During this episode, you will learn about;0:00:49 - ICH Introduction0:02:13 - The Significance of ICH E6 and E80:04:41 - The Global Impact of ICH 0:08:02 - The Evolution of Technology0:11:30 - Quality by Design 0:18:51 - Operational Feasibility0:21:16 - Complementary Guidance            Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Welcome to another episode of Queens of Quality. Join us in this podcast episode as we decode compliance and quality assurance complexities in the pharmaceutical and biotech industries with Sherice Mills, founder of ADROIT Risk Management. Sherice enlightens us on the evolution of REMS programs, their importance in patient safety, and the role of the FDA. We also delve into the challenges in leadership and innovation in these industries and the need for a partnership mentality for revolutionary ideas. The episode further explores the changing expectations of the FDA from vendors, the impact on patient safety, and the need for trusted advisors. Don't miss out on this informative conversation.Tune in!During this episode, you will learn about;0:00:32 - Guest introduction: Sherry Mills, founder of Adroit Risk Management.0:01:39 - Discussion about the history and origins of REMS programs.0:04:14 - Mention of the FDA's authority to require additional safety measures.0:06:03 - Explanation of the various components of REMS programs.0:09:12 - Discussion on the challenges of standardizing REMS programs globally.0:16:33 - Challenges in Leadership and Innovation0:18:58 - Addressing resistance to change within the pharmaceutical industry.0:20:23 - Importance of in-house expertise and trusted advisors.0:24:16 - Reference to the REMS Industry Consortium (RIC) and the need for industry collaboration.0:27:46 - Mention of upcoming workshops and exploration of AI in the industry.0:31:56 - Closing remarks and contact information.            Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Connect with Sherice Mills;LinkedIn: https://www.linkedin.com/in/shericerm/Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

In this episode of Queens of Quality, the hosts interview Cheryl McCarthy, a seasoned professional in the pharmaceutical and biotech industries. They discuss the complexities of quality and compliance, the new ICHU6R3 guidance, and the importance of explaining the rationale behind actions. The conversation also explores the evolution of quality control, the integration of Agile methodology, and the shift in quality culture towards collaboration. They conclude by discussing the role of auditors, the potential benefits of constructive feedback, and the learning opportunities presented by audits.Tune in!During this episode, you will learn about;0:00:32: Introduction of the first-ever guest, Cheryl McCarthy, her background, and her consulting group, Anchor.0:03:58: Discussion on the impact of decisions in quality assurance and risk-based approaches.0:08:12: Conversation about the proactive and preventative approach in quality management.0:15:33: Highlighting the importance of collaboration and communication in quality culture.0:18:39: Emphasizing the ultimate target in quality management, which is the patient.0:19:48: Discussion on the need for processes and controls in quality management.0:21:07: Conversation about the value of audits and opportunities for improvement.0:23:54: Acknowledgment of the importance of a collaborative and non-confrontational approach in quality management.0:27:10: Closing remarks and contact information for the podcast.            Love the show? Subscribe, Rate, Review, Like, and Share! Let’s Connect! Connect with Cheryl McCarthy;LinkedIn: https://www.linkedin.com/in/cherylmccarthy/Connect with Queens of Quality;Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com 

In this episode of the Queens of Quality podcast, we explore the importance of discussing failure alongside success in the pharmaceutical and biotech industries. With only a small percentage of drugs making it to clinical testing, failure is an integral part of the industry. We discuss the lengthy process of bringing a product to market, the challenges faced, and the significance of collaboration between academia and the industry. Join us as we delve into the complexities of drug development and the lessons learned from failures. Don't forget to subscribe, like, review, and share the podcast to help us continue the conversation.Tune in!During this episode, you will learn about;0:00:32 The Queens of Quality discuss the topic of failure0:02:05 From Bench to Bedside: Pharma Industry's Journey0:05:14 The Challenge of Identifying the Right Target0:07:57 Ensuring Support and Documentation for Clinical Phases0:10:10 Phase One Trials: High Failure Rate and Cost Implications0:12:05 Multiple Development Paths and the Importance of Phase Two0:14:22 Phase Three Trials: Expanding Patient Population and Clinical Programs0:15:52 The Final Stretch: Phase Three Programs0:16:19 The Reality: Fast-paced and Not Funny0:18:23 Long Timelines and Challenges in Clinical Trials0:20:35 Study Drug Adherence: A Critical Factor in Audits0:21:15 High Adherence Rate in Children's Oncology Study0:23:25 The Importance of Reinvestment and Balancing Product Pipeline0:25:31 Collaboration between academia and industry in pharmaceutical innovation0:28:02 Progress and success in the pharma and biotech industry0:31:16 Wrapping up the Queens of Quality Podcast            Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Leadership Support and Inspection Readiness: Ensuring Organizational ExcellenceIn this enlightening episode of "Queens of Quality," hosts Michelleanne and Jenn delve into the pivotal role of leadership support in achieving operational efficiency, inspection readiness, and organizational success. They discuss the often underestimated impact of leadership in various areas, including resources, teamwork, communication, and preparedness.  Discover how leadership support can foster a culture of open communication, acknowledge imperfections, and drive excellence across departments. Join the conversation as they share valuable insights into effective leadership practices and the key to maintaining a balanced, successful organization. Tune in!During this episode, you will learn about;[00:00:32] Introduction: Michelleanne and Jenn discuss the crucial role of leadership support in effective organizations.[00:02:28] Leadership's impact on departmental efficiency, adherence to guidelines, and overall effectiveness.[00:08:57] Emphasis on creating a safe environment for team members to share challenges, even during personal difficulties.[00:13:07] Exploring the connection between leadership actions, communication, and team members' sense of security.[00:15:27] Jenn's experience adapting leadership discussions to resonate with different perspectives.[00:19:41] Michelleanne's encounters with frequent inspections and understanding the "why" behind operations.[00:25:56] The hosts emphasize the mission-critical nature of leadership support in maintaining organizational excellence.[00:29:34]:  Call to action and closing remarks            Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com 

This podcast episode, hosted by Jen and Michelleanne, dives deep into the intricacies of pharmaceutical and biotech industries, focusing on audits, vendor qualifications, and quality compliance. The hosts unravel how health authorities are intensifying their involvement in vendor collaborations, the increasing importance of contract owners in the qualification process, and the instances where qualification audits become vital for organizations. The episode also delves into vendor qualification and audit scheduling, the role of SOPs and quality manuals, and the challenges of vendor reassessment during mergers and integrations. The conversation concludes with an exploration of respect, empathy, transparency, and open communication in vendor management and how to balance regional requirements in the qualification process. This episode is an enlightening and exciting rollercoaster ride into the world of pharmaceutical vendor management. Tune in! During this episode, you will learn about the following;0:00:31 - Start of the show and Introduction of Hosts0:02:14 - Qualification and Requalification Process Discussion0:08:32 - Misconceptions About Vendor Qualification0:19:04 - Document Access and Audit Scheduling Issues0:24:16 - The Importance of Quality in Business0:30:07 - Harmonizing Global and Local Operations0:33:29 - Assessing Data Entry Accuracy and Guidelines0:36:08 - Hosts' final thoughts and sign-off Love the show? Subscribe, Rate, Review, Like, and Share! Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Ever thought about the crucial role culture plays in the pharmaceutical and biotech industries? What if we told you it's not just about hiring quality people but also about cultivating an atmosphere of strong communication, compliance, and a deep understanding of roles and responsibilities? Welcome to season two of Queens of Quality. In our latest episode, we dissect this complex subject, peeling off the layers that often lead to group dynamics and group thinking pitfalls. We share some insights on creating a culture that doesn't just dwell on 'do what I say' but promotes trust and objectivity. Did you know the importance of humor in maintaining your sanity amidst the daily grind of hard work? We couldn't agree more! Balancing the seriousness of the work with our mental well-being is an art that needs mastering. Tune in as we discuss the art of decision-making, demonstrating our work outcomes, and proactively mitigating risks using a Risk Evaluation and Mitigation Strategy (REMS). As we delve deeper into this conversation, we also touch upon the importance of evaluating potential employers and the significance of quality control in preserving your future. Join us for insights, laughter, and shared experiences on this journey toward cultivating a culture of quality.Tune in! During this episode, you will learn about;(0:00:31) - Start of the show and Introduction of Hosts(0:01:00) - Overview of Season Two Topics(0:03:00) - Discussion on Culture of Quality(0:11:24) - The Role of Humor in the Workplace(0:16:27) - The Importance of Conservative Decision-Making and REMS(0:21:57) - The Art of Interviewing Potential Employers(0:27:03) - Maintaining Quality Control and Safeguarding Future Love the show? Subscribe, Rate, Review, Like, and Share! Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Join in another fantastic episode with your hosts, Jennifer and Michelleanne. In today’s episode, we talk about Risk Evaluation and Mitigation Strategy (REMS). We talk about the history of Thalidomide and why REMS closely monitors it. Moreover, we discuss the different pieces of REMS and the difference between Single REMS & Shared REMS.Additionally, we talk about the difference between Pharmacovigilance (PV) & REMS, The REMS Industry Consortium (RIC), and how to get started with a REMS program. Tune in! During this episode, you will learn about;[00:30] Episode introduction[00:37] Today’s theme; Risk Evaluation and Mitigation Strategy (REMS) [01:18] When was REMS started?[01:44] The history of Thalidomide and why REMS closely monitors it[07:03] Single REMS vs Shared REMS [11:20] Risk piece in REMS program [12:21] Evaluation piece in REMS program [17:35] The difference between Pharmacovigilance (PV) and REMS[18:35] Mitigation piece in REMS program [21:44] The REMS Industry Consortium (RIC) [25:28] How to get started with a REMS program[26:55] What to expect in the next episode[27:41] How to connect with us  Remember to Subscribe, Rate, Review, Like, and Share!Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Pharmacovigilance is the process of monitoring the effects of medical drugs after they have been licensed for use, especially to identify and evaluate previously unreported adverse reactions.Welcome to another incredible episode with your hosts, Jennifer and Michelleanne. In this episode, we focus on pharmacovigilance in the pharmaceutical industry. We talk about who is responsible for drug safety & pharmacovigilance, the sources of pharmacovigilance data, and pharmacovigilance in clinical trials. In addition, we discuss the Investigator’s Brochure (IB) and Adverse Event (AE) reporting policy and share how you can turn pharmacovigilance into a competitive advantage. Tune in! During this episode, you will learn about;[00:01] Episode introduction[00:35] Today’s focus; pharmacovigilance [01:23] Definition of pharmacovigilance[04:20] Who is responsible for drug safety & pharmacovigilance?[05:54] Sources of pharmacovigilance data[08:40] Pharmacovigilance in clinical trials [10:00] Adverse Event (AE) reporting policy[14:33] Investigator’s Brochure (IB)[16:30] Postmarketing surveillance and adverse drug reactions[20:03] A recap of the episode[22:21] Turning pharmacovigilance into a competitive advantage[26:04] How to connect with us Love the show? Follow, Rate, Review, Like, and Share! Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Adopting a proactive approach is one of the most important decisions any organization can make. It helps the organization to become more profitable and competitive. In addition, companies that adopt a proactive approach to quality and compliance can identify potential issues before they become problems and reduce the number of problems that arise in the future.Welcome to another incredible episode with your hosts, Jennifer and Michelleanne. Today’s episode discusses adopting a proactive approach to quality and compliance. We talk about the most significant learnings from COVID-19, acknowledging workplace mistakes, and the importance of forgiveness in the workplace. Moreover, we share the difference between a mistake and something being wrong.Tune in!During this episode, you will learn about;[00:01] Introduction to the show[00:37] Today’s theme; Taking a proactive approach[04:53] What’s Michelleanne’s biggest learning from COVID-19 as quality & compliance professional?[07:49] Jennifer’s biggest learning from COVID-19 as quality & compliance professional[11:41] Mistakes that have been made when handling the pandemic[14:26] Acknowledging workplace mistakes[16:28] Forgiveness in the workplace[17:27] Learning from the mistakes we make[21:40] The difference between a mistake and something being wrong[22:45] How to connect with us   Don’t forget to Follow, Rate, Review, Like, and Share! Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Welcome to another fantastic episode with your hosts, Jennifer and Michelleanne. In today’s episode, we talk about the regulatory landscape of the pharmaceutical industry. We focus on the role of regulatory organizations and the changes that have taken place in the regulatory process since the development of the polio vaccine. Additionally, we talk about the relationship between quality and regulatory and the importance of leveraging your regulatory department. Finally, we discuss whether firm size affects regulatory requirements and how people can ensure that they have solutions that are fit for purpose. Tune in! During this episode, you will learn about;[00:01] Episode introduction[00:35] Today’s focus; Regulatory landscape[02:21] What we took for granted pre- COVID-19[04:10] Changes that have taken place in the regulatory process since the development of the polio vaccine[08:39] What is the role of the regulatory organization[12:39] Quality vs. Regulatory[13:56] Why leveraging your regulatory department is important[16:00] European Medicines Agency (EMA) regulatory guidelines[18:22] Precision medicine (personalized medicine)[23:13] Does firm size affect regulatory requirements?[25:07] Ensuring that people have solutions that are fit for purpose[33:26] A recap of the episode[35:45] How to connect with us Love the show? Subscribe, Rate, Review, Like, and Share! Let’s Connect!● Website: https://metisconsultingservices.com/● LinkedIn: https://www.linkedin.com/company/metis-consulting-services/● Email: info@metisconsultingservices.com

The audit and inspection readiness is a process of assessing the readiness of organizations to conduct an audit or inspection. It helps ensure that organizations are ready for an audit by evaluating the risk level and identifying potential problems that could lead to audit failures. Moreover, it helps organizations identify areas for improvement so they can be more efficient in their operations.Welcome to another amazing episode with your hosts, Jennifer and Michelleanne. In today’s episode, we talk about the importance of inspections and audits, identifying the right people to be in front of an inspector, and people’s perception of inspectors & auditors. Additionally, we talk about the importance of having an audit plan or program, new trends in auditing & inspection, and the most effective way of performing an audit of your vendors. Tune in! During this episode, you will learn about;[00:02] Introduction to the show[00:33] What’s in for you in today’s episode[01:05] The importance of inspections and audits[03:34] Identifying the right people to be in front of an inspector [05:38] People’s perception of inspectors and auditors[09:54] Importance of having an audit plan or program[11:28] Why an external audit is important[17:19] New trends in auditing and inspection [20:02] Things you should not say in an audit interview[23:16] How do you perform an audit of your vendors?[24:49] Risk vs non-compliances[28:02] How to connect with us Don’t forget to Subscribe, Rate, Review, Like, and Share! Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

The pharmaceutical industry is highly regulated. Regulatory agencies require pharmaceutical companies to meet specific standards of quality and compliance. It is thus important to have a thorough understanding of what these words mean and how they are related to each other.Welcome to this amazing episode of the “Queens of Quality” podcast with your hosts, Jennifer and Michelleanne. In this episode, we share why we created the ‘Queens of Quality’ podcast and our perspectives on the difference between compliance and quality. Additionally, we talk about the importance of effective communication within an organization and why compliance and quality are important in the pharmaceutical industry.Tune in! During this episode, you will learn about;[00:01] Episode introduction[00:41] Know your hosts; Jennifer DiMarco’s bio[01:31] Michelleanne Bradley’s bio[02:39] Why we created the ‘Queens of Quality’ podcast[04:00] Michelleanne’s perspective on the difference between compliance and quality[04:14] Jennifer’s perspective on the difference between compliance and quality[07:31] Quality and compliance framework[12:54] The importance of effective communication within an organization[18:28] Why compliance and quality are important in the pharmaceutical industry[22:12] What to expect in our next episode[23:01] How to connect with us Don’t forget to Subscribe, Rate, Review, Like, and Share! Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com

Welcome to the Queens of Quality podcast with your hosts, Michelleanne Bradley &  Jennifer DiMarco. This podcast will discuss some of the basic and not-so-basic impacts of compliance and quality within the pharmaceutical and biotech industries.Join us in our biweekly podcast episodes, where we will provide direction and be trust advisors for solutions for day-to-day issues. Additionally, we will add a balance of laughter and education as we discuss and debunk some of the misconceptions about quality assurance in the pharmaceutical industry. Don’t forget to Subscribe, Rate, Review, Like, and Share! Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com